More recently, our observation of a neuroprotective effect of a CD88 antagonist[25] in two mouse models of AD added support to the hypothesis that the consequences of C5a-CD88 interactions are detrimental in the aging brain. This evidence concerns the gene C5AR1 and Alzheimer disease.